Efficacy of mustadi ghanvati with and without udvartana in hyperlipidemia on lipid profile

Randomized Controlled Trial of Efficacy of Mustadi Ghanvati With and Without Udvartana in Medoroga With Special Reference to Hyperlipidemia on Lipid Profile - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080754

Enrollment

Registered

2025-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are willing to participate in trial and ready to give written consent.Patient having minimum fifty percent symptoms of medoroga according to classics and fulfilling diagnostic criteria of this study.Male and females, aged between twenty to seventy years irrespective of caste religion socioeconomic and educational status.Patient whose lipid profile shows any one or both of the following diagnostic criteria of hyperlipidemia that is serum cholesterol 201 mg per dl upto 1000 mg per dl, Serum Triglycerides 151 mg per dl upto 1000 mg per dl will be selected.Patients of Medoroga having BMI more than 25 Kg per m2 and less than 40 Kg per m2.Patient with controlled HTN BP Systolic less than 150 and Diastolic less than 100 mmHg and DM having FBS less than 150 mg per dl and PMBS less than 250 mg per dl.Patient who had not participated in any research work since last six months will be included

Exclusion criteria

Exclusion criteria: Patients who are not willing to participate in trial and not ready to give written consent. Patients having age below 20 years and above 70 years.Patients who have uncontrolled HTN BP Systolic greater than 150 and Diastolic greater than 100 mmHg. Patients who have uncontrolled DM FBS greater than 150 mg per dl and PMBS greater than 250 mg per dl.Patients having history of serious cardiac disorders like myocardial infarction cardiac failure etc. and any other serious renal hepatic respiratory diseases etc. will also be excluded.Patients having a history of untreated thyroid disorders.Patients who are unfit for udvartana like skin disorders injury or wound hypersensitive.Drug induced hyperlipidemia like glucocorticoids induced hyperlipidemia.Pregnant females and lactating mothers.Who are currently participating in any other clinical trial from last 6 month.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in the management of Medoroga w.s.r.t. hyperlipidemia on lipid profile. To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in management of Medoroga w.s.r.t. hyperlipidaemia on symptom scale of Medoroga. To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in management of Medoroga w.s.r.t. hyperlipidaemia on anthropometric parameters.Timepoint: On 0th day, 16th day, 31st day of trial	—

Measure

Time frame

To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in the management of Medoroga w.s.r.t. hyperlipidemia on lipid profile. To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in management of Medoroga w.s.r.t. hyperlipidaemia on symptom scale of Medoroga. To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in management of Medoroga w.s.r.t. hyperlipidaemia on anthropometric parameters.Timepoint: On 0th day, 16th day, 31st day of trial

—

Secondary

Measure	Time frame
To review and study literature of Medoroga as per Ayurvedic classics. To review and study literature of hyperlipidaemia as per modern scienceTimepoint: On 0th day, 16th day, 31st day of trial	—

Countries

India

Contacts

Public ContactMayuri Madhukar Mungale

Government Ayurved College and Hospital, Nagpur

ashish.thatere@gmail.com9423406821

Outcome results